ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1989

Improving Sleep in Fibromyalgia Patients Ameliorates Their Pain

Robert S. Katz, Rush University Medical Center, Chicago, IL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Fibromyalgia and sleep

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: ARHP Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibromyalgia patients complain of poor sleep. We assessed whether patients with fibromyalgia who were able to significantly improve their sleep, including sleeping uninterrupted through the night, had less pain. It is possible that solid rest at night can lead to muscle relaxation and central nervous system rest and result in improvement in fibromyalgia symptoms.

Methods:   37 patients were given the opportunity to participate in this rheumatology office trial. Patients with diagnosed fibromyalgia according to the 2010 ACR criteria who had poor sleep were given amitriptyline, doxepin, or trazodone in gradually increasing dosages, enough for them to sleep through the night. Those who completed at least two weeks of medication therapy in doses enough to make them sleep well were further evaluated for a response in terms of pain level and fatigue.

Results: See graph below

https://acr.confex.com/data/abstract/acr/2016/Paper_56952_abstract_82751_0.jpg 

Conclusion :  In this open label, uncontrolled study, we found that many patients who are able to sleep through the night by using amitriptyline, doxepin, or trazodone had an improvement in pain and global scores for Fibromyalgia. Starting with low dosage given early in the evening, generally 7 PM, and titrating upward until uninterrupted sleep was achieved. Good sustained sleep maybe therapeutic in this illness, but to achieve that may require a significant step-wise increase in these medications until uninterrupted sleep is achieved. 

 


Disclosure: R. S. Katz, None;

To cite this abstract in AMA style:

Katz RS. Improving Sleep in Fibromyalgia Patients Ameliorates Their Pain [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/improving-sleep-in-fibromyalgia-patients-ameliorates-their-pain-2/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-sleep-in-fibromyalgia-patients-ameliorates-their-pain-2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology